Clinical Trials Browser

Pancreatic Neoplasms

NCT00087425 2015-04-30

Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00006389 2014-10-01

Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Phase 2 Completed

12 enrolled 7 charts

Gastrointestinal

Stomach Neoplasms

NCT00006942 2013-08-26

Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

32 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00005965 2013-07-10

Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

Phase 2 Completed

Gynecologic

Uterine Cervical Neoplasms

NCT00004008 2013-06-26

Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer

Phase 2 Completed

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00005056 2013-06-26

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

Phase 2 Completed

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00005599 2013-06-21

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00003968 2013-02-08

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

35 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002725 2013-02-05

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Phase 2 Completed

35 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00032188 2013-01-24

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Phase 2 Completed

65 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00058305 2013-01-10

Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation

Phase 2 Completed

28 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation